Working Together to Find the New Standard of Care

Andrey Antov, PhD, MBA

Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients.

Related Videos

November 10, 2012

PMO Interview with the Innovator Series: Volume 1

Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, [ Read More ]

October 16, 2015

Melanoma in Personalized Medicine and Biomarkers

Dr. Sanjiv Agarwala talks about the importance of personalizing melanoma care, focusing on where the industry currently stands and what’s in store for the future of targeted therapies and immunotherapies.